NCT04640454

Brief Summary

Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is a form of mastectomy that achieves optimal disease control and facilitates reconstruction. The study aimed to assess the oncological safety and aesthetic outcomes of nipple-sparing mastectomy and immediate breast reconstruction. 35 female patients with breast cancer were included in the study. The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

November 5, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 23, 2020

Completed
Last Updated

November 23, 2020

Status Verified

November 1, 2020

Enrollment Period

2 years

First QC Date

November 5, 2020

Last Update Submit

November 17, 2020

Conditions

Keywords

breast cancermastectomybreast reconstruction

Outcome Measures

Primary Outcomes (1)

  • patients complications after nipple sparing mastectomy

    Complete general examination, local examination of the skin, nipple and areola were done to determine whether the patients suffered from any complaints

    2017-2019

Secondary Outcomes (1)

  • Aesthetic results assessed by Tzafetta et al scoring system

    2017-2019

Interventions

The investigators categorized the incisions into radial, inframammary, and periareolar incisions with planned reconstruction types; direct to implant (DTI), transversus rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi myocutaneous (LD) flap, or LD with implant.

Eligibility Criteria

Age28 Years - 68 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The mean age of the studied patients was 44.00±9.47 years old; the youngest patient was 28 years old and the oldest one was 68 years old, the majority of patients were 40-50 years of age (54%) As regard the patients' marital status; 31 patients were married constituting 88.57 % and only 4 (11.4 %) patients were single The main complaint of 25 of them (71.42%) was painless breast lump while 8 cases (22.85%) presented with local recurrence after previous breast conservative surgery and only two case (5.7%) presented by extensive mammographic calcifications on screening mammography

You may qualify if:

  • Diagnosis of ductal in situ carcinoma or infiltrating ductal carcinoma with a tumor diameter up to 3 cm
  • Distance of the tumor from the nipple ≥ 2 cm
  • Cancer or microcalcifications not localized in the central field.
  • No blood secretions or other (nipple-areola complex) NAC disturbances
  • Absence of skin involvement
  • Indication to mastectomy for multifocal or diffuse microcalcifications
  • Negative intraoperative assessment of NAC-bottom

You may not qualify if:

  • Tumor or microcalcifications localized in the central quadrant or in the retroareolar region
  • Blood secretions or other NAC alterations
  • Positive intraoperative assessment of NAC-bottom
  • Inflammatory carcinoma
  • Paget's disease of the nipple

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria faculty of medicine

Alexandria, 21500, Egypt

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Mastectomy, Subcutaneous

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

MastectomySurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2020

First Posted

November 23, 2020

Study Start

January 1, 2017

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

November 23, 2020

Record last verified: 2020-11

Locations